{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:59:26Z","timestamp":1784210366022,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":2233,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008273","name":"Novartis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5 U42 RR006042"],"award-info":[{"award-number":["5 U42 RR006042"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015311","name":"Novartis Institutes for BioMedical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ajpath.2013.07.017","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T10:16:35Z","timestamp":1382523395000},"page":"1461-1473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Treatment with Anti\u2013Gremlin 1 Antibody Ameliorates Chronic Hypoxia\/SU5416\u2013Induced Pulmonary Arterial Hypertension in Mice"],"prefix":"10.1016","volume":"183","author":[{"given":"Loredana","family":"Ciuclan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KellyAnn","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas W.","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Jarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"DuBois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Van Heeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"England","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2013.07.017_bib1","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/CIRCULATIONAHA.109.927681","article-title":"Formation of plexiform lesions in experimental severe pulmonary arterial hypertension","volume":"121","author":"Abe","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2013.07.017_bib2","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpath.2013.07.017_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.pathol.2.010506.092033","article-title":"Pathobiology of pulmonary hypertension","volume":"2","author":"Rabinovitch","year":"2007","journal-title":"Ann Rev Pathol"},{"key":"10.1016\/j.ajpath.2013.07.017_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.RES.00000175934.68087.29","article-title":"Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension: a time for reappraisal?","volume":"97","author":"Stenmark","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2013.07.017_bib5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.RES.0000243584.45145.3f","article-title":"Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms","volume":"99","author":"Stenmark","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2013.07.017_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0272-5231(05)70280-X","article-title":"The pathobiology of pulmonary hypertension. Endothelium","volume":"22","author":"Tuder","year":"2001","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ajpath.2013.07.017_bib7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jacc.2009.04.009","article-title":"Development and pathology of pulmonary hypertension","volume":"54","author":"Tuder","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2013.07.017_bib8","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0167-5273(11)70490-9","article-title":"Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011","volume":"154","author":"Ghofrani","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ajpath.2013.07.017_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/14017431.2010.525747","article-title":"A novel BMPR2 gene mutation associated with exercise-induced pulmonary hypertension in septal defects","volume":"44","author":"Moller","year":"2010","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.ajpath.2013.07.017_bib10","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/ATVBAHA.107.141200","article-title":"Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension","volume":"27","author":"Morty","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2013.07.017_bib11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.healun.2008.02.009","article-title":"Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension","volume":"27","author":"Rosenzweig","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ajpath.2013.07.017_bib12","doi-asserted-by":"crossref","first-page":"L363","DOI":"10.1152\/ajplung.00295.2009","article-title":"BMPR2 mutation alters the lung macrophage endothelin-1 cascade in a mouse model and patients with heritable pulmonary artery hypertension","volume":"299","author":"Talati","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6 Suppl","key":"10.1016\/j.ajpath.2013.07.017_bib13","doi-asserted-by":"crossref","first-page":"553S","DOI":"10.1378\/chest.128.6_suppl.553S","article-title":"Suppression of type II bone morphogenic protein receptor in vascular smooth muscle induces pulmonary arterial hypertension in transgenic mice","volume":"128","author":"West","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ajpath.2013.07.017_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1755-8794-1-45","article-title":"Gene expression in BMPR2 mutation carriers with and without evidence of Pulmonary Arterial Hypertension suggests pathways relevant to disease penetrance","volume":"1","author":"West","year":"2008","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.ajpath.2013.07.017_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1165\/rcmb.2009-0101TR","article-title":"Role of gremlin in the lung development and disease","volume":"42","author":"Costello","year":"2010","journal-title":"Am J Resp Cell Mol Biol"},{"key":"10.1016\/j.ajpath.2013.07.017_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/CIRCULATIONAHA.108.821504","article-title":"Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease","volume":"119","author":"Long","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2013.07.017_bib17","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1183\/09031936.01.00202701","article-title":"Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene","volume":"17","author":"Tuder","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajpath.2013.07.017_bib18","doi-asserted-by":"crossref","first-page":"L272","DOI":"10.1152\/ajplung.00358.2007","article-title":"Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension","volume":"295","author":"Costello","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ajpath.2013.07.017_bib19","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.111.038125","article-title":"Gremlin plays a key role in the pathogenesis of pulmonary hypertension","volume":"125","author":"Cahill","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2013.07.017_bib20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/hyb.1997.16.381","article-title":"Rapid development of affinity matured monoclonal antibodies using RIMMS","volume":"16","author":"Kilpatrick","year":"1997","journal-title":"Hybridoma"},{"key":"10.1016\/j.ajpath.2013.07.017_bib21","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201103-0412OC","article-title":"A novel murine model of severe pulmonary arterial hypertension","volume":"184","author":"Ciuclan","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajpath.2013.07.017_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2353\/ajpath.2009.080565","volume":"174","author":"Thomas","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.07.017_bib23","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/j.gastro.2008.04.038","article-title":"Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage","volume":"135","author":"Dooley","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2013.07.017_bib24","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1182\/blood-2011-05-347393","article-title":"Bone morphogenetic protein receptor-II regulates pulmonary artery endothelial cell barrier function","volume":"118","author":"Burton","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2013.07.017_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.CIR.0000154543.07679.08","article-title":"Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension","volume":"111","author":"Machado","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2013.07.017_bib26","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","article-title":"Cellular and molecular basis of pulmonary arterial hypertension","volume":"54 (Suppl 1)","author":"Morrell","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpath.2013.07.017_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000322011","article-title":"The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension","volume":"81","author":"Sakao","year":"2010","journal-title":"Respiration"},{"key":"10.1016\/j.ajpath.2013.07.017_bib28","doi-asserted-by":"crossref","first-page":"L604","DOI":"10.1152\/ajplung.00309.2011","article-title":"BMP type II receptor deficiency confers resistance to growth inhibition by TGF-beta in pulmonary artery smooth muscle cells: role of proinflammatory cytokines","volume":"302","author":"Davies","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ajpath.2013.07.017_bib29","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1182\/blood-2010-06-291930","article-title":"Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2","volume":"116","author":"Mitola","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2013.07.017_bib30","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1167\/iovs.11-7587","article-title":"Role of TGF beta\/Smad signaling in gremlin induction of human trabecular meshwork extracellular matrix proteins","volume":"52","author":"Sethi","year":"2011","journal-title":"Invest Opthamol Vis Sci"},{"key":"10.1016\/j.ajpath.2013.07.017_bib31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1165\/rcmb.2010-0070OC","article-title":"Transient overexpression of gremlin results in epithelial activation and reversible fibrosis in rat lungs","volume":"44","author":"Farkas","year":"2011","journal-title":"Am J Resp Cell Mol Biol"},{"key":"10.1016\/j.ajpath.2013.07.017_bib32","doi-asserted-by":"crossref","first-page":"e11709","DOI":"10.1371\/journal.pone.0011709","article-title":"The in\u00a0vivo delivery of gremlin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by recovering bone morphogenetic protein-7","volume":"5","author":"Zhang","year":"2010","journal-title":"PLOS One"},{"key":"10.1016\/j.ajpath.2013.07.017_bib33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/glia.20803","article-title":"Bone morphogenetic protein 4 inhibits TGF-beta 2 stimulation of extracellular matrix proteins in optic nerve head cells: role of gremlin in ECM modulation","volume":"57","author":"Zode","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.ajpath.2013.07.017_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1164\/rccm.200706-945OC","article-title":"Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis","volume":"177","author":"Myllarniemi","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajpath.2013.07.017_bib35","doi-asserted-by":"crossref","first-page":"e35100","DOI":"10.1371\/journal.pone.0035100","article-title":"Gremlin-1 induces BMP-independent tumor cell proliferation, migration, and invasion","volume":"7","author":"Kim","year":"2012","journal-title":"PLOS One"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013005385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013005385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:39:47Z","timestamp":1757601587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944013005385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0002944013005385"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.07.017","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with Anti\u2013Gremlin 1 Antibody Ameliorates Chronic Hypoxia\/SU5416\u2013Induced Pulmonary Arterial Hypertension in Mice","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}